Ultragenyx Pharmaceutical Inc. buy Cantor Fitzgerald
Start price
05.04.24
/
50%
€46.40
Target price
05.04.25
€98.89
Performance (%)
-11.21%
Price
29.04.24
€41.20
Summary
This prediction is currently active. The prediction for Ultragenyx Pharmaceutical Inc. disappoints with a performance of -11.21%. This prediction currently runs until 05.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Ultragenyx Pharmaceutical Inc. | 3.518% |
| iShares Core DAX® | 0.961% |
| iShares Nasdaq 100 | 2.626% |
| iShares Nikkei 225® | 0.217% |
| iShares S&P 500 | 1.540% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $107.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.60
27.02.24
27.02.24
€98.68
27.02.25
27.02.25
-16.94%
29.04.24
29.04.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€44.60
15.02.24
15.02.24
€105.84
15.02.25
15.02.25
-7.62%
29.04.24
29.04.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€40.20
19.01.24
19.01.24
€104.83
19.01.25
19.01.25
1.49%
29.04.24
29.04.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€34.40
25.09.23
25.09.23
€107.74
25.09.24
25.09.24
18.60%
29.04.24
29.04.24